The University of Chicago Header Logo

Connection

James Dolezal to Neoadjuvant Therapy

Back to Details
This is a "connection" page, showing publications James Dolezal has written about Neoadjuvant Therapy.
James Dolezal
Connection Strength
0.180
Neoadjuvant Therapy
  1. Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC. J Thorac Oncol. 2024 Jul; 19(7):1108-1116.
    View in: PubMed
    Score: 0.180
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.